Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B

por Ergenç, İlkay, Kani, Haluk Tarık, Karabacak, Murat, Cömert Özer, Elif, Mehdiyev, Shahin, Jafarov, Fuad, Abacar, Kerem Yiğit, Kutluğ Ağaçkıran, Seda, Sevik, Gizem, Aslan, Rahmi, Alibaz Öner, Fatma, İnanç, Nevsun, Atagündüz, Mehmet Pamir, Seçkin, Dilek, Özen Alahdab, Yeşim, Ergun, Tülin, Direskeneli, Haner, Atuğ, Özlen
Publicado 2023

RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy

por Ergenç, İlkay, Tarık Kani, Haluk, Karabacak, Murat, Cömert Özer, Elif, Mehdiyev, Shahin, Jafarov, Fuad, Yiğit Abacar, Kerem, Kutluğ Ağaçkıran, Seda, Sevik, Gizem, Aslan, Rahmi, Alibaz Öner, Fatma, İnanç, Nevsun, Pamir Atagündüz, Mehmet, Seçkin, Dilek, Özen Alahdab, Yeşim, Ergun, Tülin, Direskeneli, Haner, Atuğ, Özlen
Publicado 2023